Treatment of ranula in pediatric patients with intralesional injection of OK-432

Heung Man Lee, Hyun Woo Lim, Hee Joon Kang, Sung Won Chae, Soon Jae Hwang, Kwang Yoon Jung, Jeong Soo Woo

Research output: Contribution to journalReview articlepeer-review

21 Citations (Scopus)


OBJECTIVE: To assess the efficacy of treatment of a ranula in children by intralesional injection of OK-432. STUDY DESIGN:: Retrospective analysis of 13 cases. METHODS: Review of medical records of pediatric patients with ranula treated by OK-432 sclerotherapy from 2002 through 2005. RESULTS: Among 13 cases, 9 were completely regressed by injection therapy alone. Three cases were incompletely regressed. One case was cured by surgical excision. The follow-up duration was 6 to 46 (mean 24.3) months. Adverse effects of OK-432 injection were tolerable, and no complication was observed. CONCLUSIONS: On the basis of our experience, sclerotherapy with OK-432 was a safe and effective primary treatment for a ranula in children. Further study will be needed to conclude its long-term effectiveness.

Original languageEnglish
Pages (from-to)966-969
Number of pages4
Issue number6
Publication statusPublished - 2006 Jun


  • Children
  • OK-432
  • Ranula

ASJC Scopus subject areas

  • Otorhinolaryngology


Dive into the research topics of 'Treatment of ranula in pediatric patients with intralesional injection of OK-432'. Together they form a unique fingerprint.

Cite this